A ganglionic blocker and adrenoceptor ligands modify clozapine-induced insulin resistance.

Autor: Yuen JWY; Faculty of Medicine, Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada., Wu C; Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Vancouver V6T 1Z3, BC, Canada., Wang CK; Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Vancouver V6T 1Z3, BC, Canada., Kim DD; Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Vancouver V6T 1Z3, BC, Canada., Procyshyn RM; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Panenka WG; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Honer WG; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Barr AM; Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Vancouver V6T 1Z3, BC, Canada. Electronic address: al.barr@ubc.ca.

Publikováno v: Psychoneuroendocrinology [Psychoneuroendocrinology] 2021 Jul; Vol. 129, pp. 105257. Date of Electronic Publication: 2021 May 12.